AmCad BioMed Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	792	931	1,415	1,422	849	1,030
Market Cap Growth	-39.47%	-34.23%	-0.45%	67.51%	-17.57%	0.26%
Enterprise Value	511	639	1,050	1,236	617	758
Last Close Price	12.50	14.70	22.35	26.12	15.60	18.93
PS Ratio	26.01	30.59	26.66	21.79	13.77	12.00
PB Ratio	1.32	1.55	2.13	2.98	1.63	1.78
P/TBV Ratio	1.72	2.02	2.82	4.63	2.48	2.62
EV/Sales Ratio	16.78	20.99	19.77	18.94	10.01	8.84
Debt / Equity Ratio	0.01	0.01	0.02	0.03	0.02	0.03
Net Debt / Equity Ratio	-0.60	-0.60	-0.53	-0.57	-0.62	-0.61
Net Debt / EBITDA Ratio	4.65	4.65	6.75	6.61	6.23	15.19
Net Debt / FCF Ratio	7.60	7.60	6.43	6.51	9.21	8.63
Asset Turnover	0.05	0.05	0.09	0.12	0.11	0.14
Inventory Turnover	0.71	0.71	0.73	1.00	1.06	1.17
Quick Ratio	20.66	20.66	15.21	12.23	12.26	14.43
Current Ratio	22.62	22.62	16.63	13.35	13.15	15.33
Return on Equity (ROE)	-11.29%	-11.29%	-9.26%	-8.65%	-9.89%	-4.58%
Return on Assets (ROA)	-8.34%	-8.34%	-6.69%	-6.33%	-6.87%	-3.61%
Return on Capital Employed (ROCE)	-14.50%	-14.50%	-9.70%	-11.10%	-12.20%	-6.20%
Earnings Yield	-7.04%	-5.99%	-3.57%	-3.19%	-6.30%	-2.48%
FCF Yield	-5.99%	-5.10%	-3.85%	-2.95%	-4.10%	-4.01%
Buyback Yield / Dilution	-9.75%	-9.75%	-8.42%	-0.01%	-	-0.09%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.